Jim Simons
BVS icon

Jim Simons’s Bioventus BVS Stock Holding History

Jim Simons’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.47M Sell
489,460
-125,640
-20% -$1.05M 0.01% 1441
2025
Q4 		$4.58M Sell
615,100
-196,100
-24% -$1.41M 0.01% 1361
2025
Q3 		$5.43M Buy
811,200
+20,382
+3% +$141K 0.01% 1443
2025
Q2 		$5.24M Buy
790,818
+237,318
+43% +$1.68M 0.01% 1495
2025
Q1 		$5.06M Buy
553,500
+164,800
+42% +$1.65M 0.01% 1424
2024
Q4 		$4.08M Buy
388,700
+800
+0.2% +$9.46K 0.01% 1579
2024
Q3 		$4.64M Sell
387,900
-115,275
-23% -$997K 0.01% 1490
2024
Q2 		$2.89M Buy
503,175
+402,841
+401% +$2.21M ﹤0.01% 1636
2024
Q1 		$522K Sell
100,334
-34,911
-26% -$171K ﹤0.01% 2844
2023
Q4 		$713K Buy
135,245
+55,445
+69% +$219K ﹤0.01% 2592
2023
Q3 		$263K Buy
+79,800
New +$280K ﹤0.01% 2992
2021
Q4 		– Sell
-23,900
Closed -$338K – 3911
2021
Q3 		$338K Sell
23,900
-62,100
-72% -$956K ﹤0.01% 3040
2021
Q2 		$1.51M Buy
+86,000
New +$1.39M ﹤0.01% 2433

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Jim Simons's BVS Position: Q1 2026 in Review

Jim Simons reduced its Bioventus (BVS) stake by 20% in Q1 2026, selling an estimated $1.05M and leaving 489,460 shares worth $4.47M. The position accounts for 0.01% of the portfolio, ranked #1441.

Jim Simons first reported a position in BVS in Q2 2021 and has held it in 13 quarters since. The position peaked at $5.43M in Q3 2025. 157 funds tracked by Wall St. Rank hold BVS as of Q1 2026.

  • Jim Simons held 489,460 shares of Bioventus worth $4.47M as of Q1 2026.
  • Jim Simons sold 125,640 Bioventus shares in Q1 2026, an estimated $1.05M.
  • Bioventus made up 0.01% of Jim Simons's portfolio in Q1 2026, its #1441 holding.
  • Jim Simons first reported a position in Bioventus in Q2 2021 and has held it in 13 quarters since.
  • Jim Simons's Bioventus position peaked at $5.43M in Q3 2025.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.